q1medicare.com
Powered by Q1Group LLC
A non-government resource for the Medicare community
Powered by Q1Group LLC
A non-government Medicare community resource
  • Menu ☰
  • Home
  • Contact
  • MAPD
  • PDP
  • 2024
  • 2025
  • FAQs
  • Articles
  • Search ⌕
  • Contact
  • 2024
  • 2025
  • FAQs
  • Articles
  • Latest Medicare News
  • Search ⌕

June 2019 Drug List Updates: Thirty (30) Medications Now Added to 2019 Medicare Part D Drug Plan Formularies

Category: Monthly Formulary Changes
Published: Jun, 24 2019 11:06:47
< Previous
Next >
The June 2019 Medicare Part D plan formulary (drug lists) data includes the addition of 44 new National Drug Codes (NDCs) to the Medicare Part D program.  These NDCs represent 30 different drugs, many with multiple strengths.

Twelve Generic Drugs Introduced: See our article https://Q1News.com/755.html for highlights of the new generics.

Five Brand-Name Drugs Introduced
In addition, 5 newly introduced brand-name drugs, some with multiple strengths, were added to Medicare Part D plan formularies.  These drugs include, BIJUVA®, CABLIVI®, DOVATO®, KRINTAFEL®, and MOTEGRITY®.

What is the NDC?
The NDC or National Drug Code is used to uniquely identify a particular drug, manufacturer, strength, and packaging combination. The NDC is often shown on your prescription bottle as an 11-digit code (see the charts below) or could be formatted as 00000-0000-00 where the first set of numbers identifies the drug manufacturer, the second set of number identifies the product and strength, and the third set of numbers identifies the packaging.  You can read more here: Q1FAQ.com/155

There are many reasons for NDCs to be added to the Medicare Part D program, a summary for all 44 new NDCs is as follows:

Reason for NDC Addition Occurrences
New Delivery Form 2
New Delivery Form and Strength 1
New Drug 13
New Drug and Strength 17
New Manufacturer and Strength 4
New Strength 7
Total New NDCs 44

Reminder: (1) Medicare Part D plans (PDPs and MAPDs) can change their formulary or drug list during the year and may drop one of your formulary medication mid-year for specific Medicare-allowable reasons (such as a new generic drug is available), but there are steps you can take if your medication is no longer covered by your prescription drug plan. (2) Your Medicare Part D plan will notify you if the plan drops a medication you are currently using.

The following chart details the 44 new manufacturer / drug-strength / packaging combinations (NDCs) that were added to one or more Medicare Part D formularies in the most recent updates. You can click on the Drug Code (NDC) or Drug Name below to go to our Q1Medicare.com Drug Finder (Q1Rx.com) to see the details of how this drug is covered by all Medicare Part D Plans in Florida -- You can then change the state to your state for details in your service area.


NDC Drug Name Notes
55513084301 AIMOVIG 140 MG/ML AUTOINJECTOR New Drug and Strength
55513084101 AIMOVIG 70 MG/ML AUTOINJECTOR New Drug and Strength
66993014130 ALISKIREN 150 MG TABLET [Tekturna] New Drug and Strength
66993014230 ALISKIREN 300 MG TABLET [Tekturna] New Drug and Strength
50261021130 BIJUVA 1 MG-100 MG CAPSULE New Drug
58468022501 CABLIVI 11 MG KIT New Drug
43598034175 CLOCORTOLONE 0.1% CREAM PUMP (g) [Cloderm] New Drug
60505397206 CYCLOBENZAPRINE ER 15 MG CAPSULE ER 24H [Amrix] New Drug and Strength
60505397306 CYCLOBENZAPRINE ER 30 MG CAPSULE ER 24H [Amrix] New Drug and Strength
69067010204 DEXCHLORPHENIRAMINE 2 MG/5 ML SYRUP [RyClora] New Drug
59762041102 DICLOFENAC EPOLAMINE 1.3% PATCH TD12 [Flector] New Drug
49702024613 DOVATO 50-300 MG TABLET New Drug
00713070915 FLUOCINOLONE 0.025% CREAM (g) [Synalar] New Drug
66993058497 FLUTICASONE-SALMETEROL 100-50 BLST W/DEV [Advair] New Manufacturer and Strength
66993058597 FLUTICASONE-SALMETEROL 250-50 BLST W/DEV [Advair] New Manufacturer and Strength
66993058697 FLUTICASONE-SALMETEROL 500-50 BLST W/DEV [Advair] New Manufacturer and Strength
00023603003 GENERESS FE CHEWABLE TABLET New Drug
58160082501 HAVRIX 720 UNITS/0.5 ML VIAL New Strength
00173088939 KRINTAFEL 150 MG TABLET New Drug
42358010310 LEVORPHANOL 3 MG TABLET New Strength
24208050707 LOTEMAX SM 0.38% OPHTH GEL DROPS New Strength
54092054601 MOTEGRITY 1 MG TABLET New Drug and Strength
54092054701 MOTEGRITY 2 MG TABLET New Drug and Strength
00069029310 NIVESTYM 300 MCG/ML VIAL New Strength
00069029410 NIVESTYM 480 MCG/1.6 ML VIAL New Strength
75834011201 OFLOXACIN 400 MG TABLET [Floxin] New Drug
62541040310 PANCREAZE DR 10,500 UNIT CAPSULE DR New Drug and Strength
62541040410 PANCREAZE DR 16,800 UNIT CAPSULE DR New Drug and Strength
62541040110 PANCREAZE DR 2,600 UNIT CAPSULE DR New Drug and Strength
62541040510 PANCREAZE DR 21,000 UNIT CAPSULE DR New Drug and Strength
62541040210 PANCREAZE DR 4,200 UNIT CAPSULE DR New Drug and Strength
00469123050 PROGRAF 0.2 MG GRANULE PACKET New Delivery Form and Strength
00469133050 PROGRAF 1 MG GRANULE PACKET New Delivery Form
70954014810 PYRIDOSTIGMINE 60 MG/5 ML SOLN SYRUP [Mestinon] New Drug
68180035507 RANOLAZINE ER 1,000 MG TABLET ER 12H [Ranexa] New Drug and Strength
68180035407 RANOLAZINE ER 500 MG TABLET ER 12H [Ranexa] New Drug and Strength
15370015004 RYCLORA 2 MG/5 ML SOLUTION SYRUP New Drug
42195012707 TAPERDEX 7 DAY 1.5 MG TABLET DS PACK New Strength
50102022423 TARINA 24 FE 1 MG-20 MCG TABLET [Tarina Fe 1/20] New Strength
57894064011 TREMFYA 100 MG/ML AUTOINJECTOR New Delivery Form
52817060138 VERSACLOZ 50 MG/ML ORAL SUSPENSION New Drug
64950042530 YOSPRALA DR 325-40 MG TABLET IR DR New Drug and Strength
64950042430 YOSPRALA DR 81-40 MG TABLET IR DR New Drug and Strength
00781531501 ZOLPIDEM TARTRATE ER 6.25 MG TABLET MPHASE [Ambien CR] New Manufacturer and Strength





Our online Formulary Browser and Drug Finder
You can review any Medicare plan formulary using the Q1Medicare.com FormularyBrowser found at: FormularyBrowser.com or compare how any medication is covered on all Medicare plans in your Service Area using our Drug Finder found at: Q1Rx.com.

Additional Formulary Drug Change Articles:

Medicare Part D Plan Formulary (Drug Lists) Updates:
September 2023, August 2023, June 2023, May 2023, April 2023, March 2023, February 2023, August 2022, June 2022, May 2022, April 2022, March 2022, February 2022, August 2021, June 2021, May 2021, April 2021, September 2020, August 2020, June 2020, May 2020, April 2020, March 2020, September 2019, July 2019, June 2019, May 2019, April 2019, March 2019, August 2018, July 2018, June 2018, May 2018, April 2018, August 2017, July 2017, May 2017, April 2017, August 2016, July 2016, June 2016, April 2016, March 2016, October 2015, August 2015, July 2015, May 2015, April 2015, August 2014, May 2014, August 2013, June 2013, May 2013, April 2013, August 2012, July 2012, June 2012

Formulary Changes to the Top Medicare Drugs:
September 2023, September 2022, September 2021, September 2020, April 2020, September 2019, April 2019, August 2018, April 2018, August 2017, April 2017, August 2016, April 2016, October 2015, April 2015, August 2014, August 2013, April 2013

New Generic Equivalents Added to Formularies:
June 2023, February 2023, August 2021, June 2021, May 2021, April 2021, September 2020, August 2020, June 2020, May 2020, April 2020, March 2020, September 2019, July 2019, June 2019, May 2019, April 2019, March 2019, August 2018, July 2018, April 2018, August 2017, July 2017, April 2017, March & April 2016, April & May 2015, August 2014, May 2014


News Home
< Previous   Next >




Medicare Supplements
fill the gaps in your
Original Medicare
1. Enter Your ZIP Code:
» Medicare Supplement FAQs


News Categories
Selecting Your Medicare Plan
Star Ratings & Plan Quality
Annual Medicare Plan Changes
Enrollment Topics
Late Enrollment Penalty
Your Formulary (Drug List)
Monthly Formulary Changes
Your Medicare Plan Coverage
Pharmacies & Providers
Changing Medicare Plans
Special Enrollment Periods SEP
The Donut Hole or Coverage Gap
Donut Hole Discounts
Straddle Claims and High Costs
Out of Pocket: TrOOP and MOOP
Medicaid, LIS, & Extra Help
IRMAA - for Higher Incomes
Medicare Advantage Plans MAPD
Medicare Supplements - Medigap
Medicare Plan Providers
Marketing Medicare Products
General Medicare Part D PDP
General Medicare
Diabetes and Diabetic Coverage
Your Health & Wellness
About Q1Medicare.com




© Q1Group LLC 2005 - 2024  



Tips & Disclaimers
  • Q1Medicare®, Q1Rx®, and Q1Group® are registered Service Marks of Q1Group LLC and may not be used in any advertising, publicity, or for commercial purposes without the express authorization of Q1Group.
  • The Medicare Advantage and Medicare Part D prescription drug plan data on our site comes directly from Medicare and is subject to change.
  • Medicare has neither reviewed nor endorsed the information on our site.
  • We provide our Q1Medicare.com site for educational purposes and strive to present unbiased and accurate information. However, Q1Medicare is not intended as a substitute for your lawyer, doctor, healthcare provider, financial advisor, or pharmacist. For more information on your Medicare coverage, please be sure to seek legal, medical, pharmaceutical, or financial advice from a licensed professional or telephone Medicare at 1-800-633-4227.
  • We are an independent education, research, and technology company. We are not affiliated with any Medicare plan, plan carrier, healthcare provider, or insurance company. We are not compensated for Medicare plan enrollments. We do not sell leads or share your personal information.
  • Benefits, formulary, pharmacy network, provider network, premium and/or co-payments/co-insurance may change on January 1 of each year. Our PDPCompare.com and MACompare.com provide highlights of annual plan benefit changes.
  • The benefit information provided is a brief summary, not a complete description of benefits. For more information contact the plan.
  • Limitations, copayments, and restrictions may apply.
  • We make every effort to show all available Medicare Part D or Medicare Advantage plans in your service area. However, since our data is provided by Medicare, it is possible that this may not be a complete listing of plans available in your service area. For a complete listing please contact 1-800-MEDICARE (TTY users should call 1-877-486-2048), 24 hours a day/7 days a week or consult www.medicare.gov.
    Statement required by Medicare:
    "We do not offer every plan available in your area. Any information we provide is limited to those plans we do offer in your area. Please contact Medicare.gov or 1-800-MEDICARE to get information on all of your options."
  • When enrolling in a Medicare Advantage plan, you must continue to pay your Medicare Part B premium.
  • Medicare beneficiaries with higher incomes may be required to pay both a Medicare Part B and Medicare Part D Income Related Monthly Adjustment Amount (IRMAA). Read more on IRMAA.
  • Medicare Advantage plans that include prescription drug coverage (MAPDs) are considered Medicare Part D plans and members with higher incomes may be subject to the Medicare Part D Income Related Monthly Adjustment Amount (IRMAA), just as members in stand-alone Part D plans. In certain situations, you can appeal IRMAA.
  • You must be enrolled in both Medicare Part A and Part B to enroll in a Medicare Advantage plan. Members may enroll in a Medicare Advantage plan only during specific times of the year. Contact the Medicare plan for more information.
  • If you are enrolled in a Medicare plan with Part D prescription drug coverage, you may be eligible for financial Extra Help to assist with the payment of your prescription drug premiums and drug purchases. To see if you qualify for Extra Help, call: 1-800-MEDICARE (1-800-633-4227). TTY users should call 1-877-486-2048, 24 hours a day/ 7 days a week or consult www.medicare.gov; the Social Security Office at 1-800-772-1213 between 7 a.m. and 7 p.m., Monday through Friday. TTY users should call, 1-800-325-0778; or your state Medicaid Office.
  • Medicare evaluates plans based on a 5-Star rating system. Star Ratings are calculated each year and may change from one year to the next.
  • A Medicare Advantage Private Fee-for-Service plan (PFFS) is not a Medicare supplement plan. Providers who do not contract with the plan are not required to see you except in an emergency.
  • Disclaimer for Institutional Special Needs Plan (SNP): This plan is available to anyone with Medicare who meets the Skilled Nursing Facility (SNF) level of care and resides in a nursing home.
  • Disclaimer for Dual Eligible (Medicare/Medicaid) Special Needs Plan (SNP): This plan is available to anyone who has both Medical Assistance from the State and Medicare. Premiums, co-pays, co-insurance, and deductibles may vary based on the level of Extra Help you receive. Please contact the plan for further details.
  • Disclaimer for Chronic Condition Special Needs Plan (SNP): This plan is available to anyone with Medicare who has been diagnosed with the plan specific Chronic Condition.
  • Medicare MSA Plans combine a high deductible Medicare Advantage Plan and a trust or custodial savings account (as defined and/or approved by the IRS). The plan deposits money from Medicare into the account. You can use this money to pay for your health care costs, but only Medicare-covered expenses count toward your deductible. The amount deposited is usually less than your deductible amount, so you generally have to pay out-of-pocket before your coverage begins.
  • Medicare MSA Plans do not cover prescription drugs. If you join a Medicare MSA Plan, you can also join any separate (stand-alone) Medicare Part D prescription drug plan
  • There are additional restrictions to join an MSA plan, and enrollment is generally for a full calendar year unless you meet certain exceptions. Those who disenroll during the calendar year will owe a portion of the account deposit back to the plan. Contact the plan provider for additional information.
  • Medicare beneficiaries may enroll through the CMS Medicare Online Enrollment Center located at www.medicare.gov.
  • Medicare beneficiaries can file a complaint with the Centers for Medicare & Medicaid Services by calling 1-800-MEDICARE 24 hours a day/7 days or using the medicare.gov site. Beneficiaries can appoint a representative by submitting CMS Form-1696.
.